Chemistry and Life Sciences Patents

The Chemistry and Life Sciences Patents Group has more than 50 members who practice intellectual property (IP) law almost exclusively. Most have doctoral degrees in diverse fields, such as organic and inorganic chemistry, molecular biology, pharmacology, virology, medicinal chemistry, and plant genetics. Many have experience in government, industry, and academia in a variety of positions—as researchers, consultants, patent examiners, and Board members at the USPTO, as well as corporate counsel responsible for domestic operations, including sales, large-scale IP portfolio management and strategic competitor and market analysis.

In the field of chemistry, we represent diverse clients in pharmaceuticals, polymers, organometallics, specialty chemicals and other fields. Morgan Lewis lawyers have particular experience in the following areas:

• Pharmaceuticals: therapeutics, carriers, diagnostics and kits
• Industrial chemicals: polymers, plastics, films, resins, latexes, adhesives, inks, dyes, pigments, colorants, explosives, propellants and batteries
• Metallics/organometallics: alloys, metallurgics, catalysts, conductive polymers and films and anticancer formulations
• Specialty chemicals: composites, fibers, nanotubes, optical coatings, surfactants, porcelains

In life sciences, including biotechnology, Morgan Lewis represents clients in a broad range of traditional pharmaceutical as well as cutting-edge technologies, including immunology, virology, molecular biology, animal and plant genetics, gene therapy, protein chemistry, pharmacology, enzymology, bioinformatics and others. Specific areas of expertise include recombinant cytokines, recombinant antigens and vaccines, antisense technology, cloning, differential display technologies, yeast fermentation, genomics and genetic engineering, immunoassay methods, rational drug design and the synthesis and screening of combinatorial libraries.